STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CDTX CIDARA THERAPEUTICS INCORPORATED StockScouter® Report

6

StockScouter® Score

CIDARA THERAPEUTICS INCORPORATED, a micro cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
  • Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral

 

Concerns

  • Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

C
F
B
F

Previous Ratings

8
5
4